JD
Jeff Dallager
VP and Corporate Controller

Jeff Dallager insider trades: St Jude Medical (STJ) stock sales

VP and Corporate Controller, St Jude Medical Last trade Dec 21, 2015 11 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
4
Open-market trades
since 2014
1
Company
last trade 2015

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jeff reports to the SEC

Open-market buys and sales

4 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 21, 2015STJ↓ Sell10b5-1$31K
Dec 19, 2014STJ↓ Sell$27K
Dec 16, 2014STJ↓ Sell$7K
Oct 29, 2014STJ↓ Sell$1.2M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jeff Dallager's insider trades

Jeff Dallager is VP and Corporate Controller at St Jude Medical (STJ). Since Oct 29, 2014, Jeff has reported no open-market purchases and 4 sales worth $1.3M on SEC Form 4. There have been no open-market trades in the last 12 months.

1 sale (2% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include option exercises (5 filings), shares withheld for taxes (4 filings), grants and awards (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every STJ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.